Registration number: 12507757

AYI Pharma Consulting Ltd

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

AYI Pharma Consulting Ltd

Company Information

Directors

Dr A Young Dr B W Young

Registered office

20 Beaulieu Gardens West Bridgford Nottingham NG2 7TL

Accountants

Rafton Associates Ltd 8 Woodland Close Markfield Leicestershire LE67 9QH

AYI Pharma Consulting Ltd

(Registration number: 12507757)
Balance Sheet as at 31 March 2026

	2026 £	2025 £
Fixed assets	654	383
Current assets	71,093	87,820
Prepayments and accrued income	140	140
Creditors: Amounts falling due within one year	(970)	(5,545)
Net current assets	70,263	82,415
Total assets less current liabilities	70,917	82,798
Accruals and deferred income	(1,020)	(850)
	69,897	81,948
Capital and reserves	69,897	81,948

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
20 Beaulieu Gardens
West Bridgford
Nottingham
NG2 7TL

These financial statements were authorised for issue by the Board on 27 May 2026.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

AYI Pharma Consulting Ltd

(Registration number: 12507757)
Balance Sheet as at 31 March 2026

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 27 May 2026 and signed on its behalf by:
 

......................................... Dr A Young Director